Study of Tomotherapy HD in Medulloblastoma

Status Recruiting

Clinical Trial Summary

The aim of the study was to improve local control and long-term survival in children with medulloblastoma, reduce the side effects of treatment and improve quality of life.

Clinical Trial Description

The technical advantages of Tomotherapy HD in the radiotherapy of children medulloblastoma (advantages in clinical operation and physics) were transformed into clinical advantages, and the possible mechanisms were explored. ;

Study Design

Related Conditions & MeSH terms

Medulloblastoma

Clinical Trial Details

NCT number	NCT03675230
Study type	Interventional
Source	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Contact	chuanying zhu, MD
Phone	13795327309
Email	zhuchuanying@xinhuamed.com.cn
Status	Recruiting
Phase	N/A
Start date	January 12, 2018
Completion date	June 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01326104` - Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor	Phase 2
Recruiting	`NCT04081701` - 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.	Phase 4
Completed	`NCT03273712` - Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)	Phase 2
Completed	`NCT00994071` - A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors	Phase 1
Active, not recruiting	`NCT02875314` - HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors	Phase 4
Completed	`NCT02441062` - Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors	Phase 2
Completed	`NCT01171469` - Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor	Phase 1
Completed	`NCT00520936` - A Study of Pemetrexed in Children With Recurrent Cancer	Phase 2
Completed	`NCT03257631` - A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors	Phase 2
Recruiting	`NCT04541082` - Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms	Phase 1
Recruiting	`NCT04337177` - Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors	Phase 1
Completed	`NCT02502708` - Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors	Phase 1
Completed	`NCT01208831` - An East Asian Study of LDE225	Phase 1
Completed	`NCT01505569` - Auto Transplant for High Risk or Relapsed Solid or CNS Tumors	N/A
Recruiting	`NCT04049669` - Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG	Phase 2
Recruiting	`NCT05125666` - Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection	Phase 2
Completed	`NCT03043391` - Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children	Phase 1
Recruiting	`NCT05278208` - Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT02724579` - Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma	Phase 2
Recruiting	`NCT04402073` - Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma	Phase 2